Ignite Creation Date:
2024-05-05 @ 10:17 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00003847
Status:
TERMINATED
Last Update Posted:
2013-09-05
First Post:
1999-11-01
Brief Title:
VX-710 Doxorubicin and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Vertex Pharmaceuticals Incorporated
Organization Data
Organization:
Vertex Pharmaceuticals Incorporated
Class:
INDUSTRY
Study ID:
CDR0000067008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Vertex Pharmaceuticals Incorporated
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None